Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics ( (AU:PER) ) has issued an update.
Percheron Therapeutics has notified the market of the issue of 13,750,000 unquoted options under the ASX code PERAQ, expiring on April 15, 2028, as well as 13,750,000 additional unquoted options in a new class exercisable at $0.01 by the same expiry date. These unquoted securities, which are not intended to be listed, form part of previously announced transactions and may influence future capital structure and potential dilution for existing shareholders while serving as incentives or consideration in the company’s ongoing activities.
More about Percheron Therapeutics
Percheron Therapeutics Limited is a biotechnology company listed on the ASX under the code PER. The company operates in the therapeutic development sector, focusing on discovering and advancing medical treatments, though specific product candidates or therapeutic areas were not detailed in this notice.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.61M
For detailed information about PER stock, go to TipRanks’ Stock Analysis page.